英文原著

1. Fujiki S, Tanaka A, Imai T, Shimabukuro M, Uehara H, Nakamura I, Matsunaga K, Suzuki M, Kashimura T, Minamino T, Inomata T, Node K. Body fluid regulation via chronic inhibition of sodium-glucose cotransporter-2 in patients with heart failure: a post hoc analysis of the CANDLE trial. Clin Res Cardiol 2023:112;87-97 pubmed

2. Hashimoto K, Nakano H, Sakai A, Shimabukuro M, Kazama JJ, Takahashi A, Ohira T, Hashimoto S, Tsubokura M, Watanabe K, Hayashi F, Nagao M, Okazaki K, Sato S, Yasumura S, Ohto H, Kamiya K, Hosoya M. Blood data trends of children in Fukushima after the Great East Japan Earthquake: Fukushima health management survey. Pediatr Int 2023;65:e15656  pubmed

3. Honda K, Okazaki K, Tanaka K, Kobari E, Kazama S, Hashimoto S, Ohira T, Sakai A, Yasumura S, Maeda M, Yabe H, Hosoya M, Takahashi A, Harigane M, Nakano H, Hayashi F, Nagao M, Shimabukuro M, Ohto H, Kamiya K, Kazama JJ. Relationship between evacuation after the Great East Japan Earthquake and new-onset hyperuricemia: A 7-year prospective longitudinal study of the Fukushima Health Management Survey. PLoS ONE 2023;18:e0293459  pubmed

4. Hosoya M, Nakano H, Hashimoto K, Ohira T, Sakai A, Shimabukuro M, Yasumura S, Ohto H, Kamiya K. Influence of post-disaster evacuation on childhood obesity and liver dysfunction. Pediatr Int 2023;65:e15663  pubmed

5. Ikeda S, Ikeda A, Ohira T, Sakai A, Shimabukuro M, Maeda M, Yabe H, Nagao M, Yasumura S, Ohto H, Kamiya K, Tanigawa T. Longitudinal Trends in Blood Pressure Associated with The Changes in Living Environment Caused by the Great East Japan Earthquake: The Fukushima Health Management Survey. Int J Environ Res Public Health 2023;20:857 pubmed 

6. Kawasaki Y, Nakano H, Hayashi F, Hosoya M, Yasumura S, Ohira T, Satoh H, Suzuki H, Takahashi A, Sakai A, Shimabukuro M, Ohto H, Kamiya K. Obesity and glucose metabolism abnormalities by post-disaster evacuation. Pediatr Int 2023;65:e15400 pubmed 

7. Kimura H, Tanaka K, Saito H, Iwasaki T, Watanabe S, Kazama S, Shimabukuro M, Asahi K, Watanabe T, Kazama JJ. Association of polypharmacy with incidence of CKD: a retrospective cohort study. Clin Exp Nephrol 2023;27:272-278  pubmed

8. Kimura H, Tanaka K, Saito H, Iwasaki T, Kazama S, Shimabukuro M, Asahi K, Watanabe T, Kazama JJ. Impact of red blood cell distribution width-albumin ratio on prognosis of patients with CKD. Sci Rep 2023;13:15774 pubmed

9. Kudo A , Machii N, Ono T, Saito H, Oshiro Y, Takahashi T, Oshiro K, Taneda Y, Higa M, Nakachi K, Yagi S, Masuzaki H, Sata M, Shimabukuro M. Effect of dapagliflozin on 24-h glycaemic variables in Japanese patients with type 2 diabetes mellitus receiving basal insulin supported oral therapy (DBOT): a multicentre, randomised, open-label, parallel-group study. BMJ Open Diabetes Res Care 2023;11:e003302 pubmed

10. Saito H, Tanaka K, Iwasaki T, Oda A, Watanabe S, Kobari E, Kimura H, Kazama S, Shimabukuro M, Asahi K, Watanabe T, Kazama JJ. Hematological parameters of anemia and prognosis of non-dialysis-dependent chronic kidney disease: the Fukushima CKD cohort study. Clin Exp Nephrol 2023:27;55-65 pubmed

11. Shiroma K, Tanabe H, Takiguchi Y, Yamaguchi M, Sato M, Saito H, Tanaka K, Masuzaki H, Kazama JJ, Shimabukuro M. A nutritional assessment tool, GNRI, predicts sarcopenia and its components in type 2 diabetes mellitus: A Japanese cross-sectional study. Front Nutr 2023;10:1087471 pubmed

12. Takahashi A, Ohira T, Hayashi F, Yasumura S, Shimabukuro M, Sakai A, Maeda M, Yabe H, Hosoya M, Kazama JJ, Hashimoto K, Nakano H, Nagao M, Sato S, Okazaki K, Harigane M, Ohto H, Kamiya K, Ohira H. Impact of Lifestyle and Psychosocial Factors on the Incidence of Hepatobiliary Enzyme Abnormalities After the Great East Japan Earthquake: Seven-Year Follow-up of the Fukushima Health Management Survey. Disaster Med Public Health Prep 2023;17:e441 pubmed

13. Tanaka A, Okada Y, Torimoto K, Kamei N, Hirai H, Kono T, Sugimoto K, Teragawa H, Taguchi I, Maruhashi T, Sonoda S, Kurozumi A, Inagaki S, Oshita C, Hisauchi I, Takahashi K, Higashi Y, Shimabukuro M, Node K. Effect of ipragliflozin on endothelial dysfunction in patients with type 2 diabetes and chronic kidney disease: A randomized clinical trial (PROCEED). Diabetes Metab 2023;49:101447 pubmed

14. Tanaka A, Taguchi I, Hisauchi I, Yoshida H, Shimabukuro M, Hongo H, Ishikawa T, Kadokami T, Yagi S, Sata M, Node K. Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA). Eur J Med Res 2023;28:238 pubmed 

15. Tanaka A, Shibata H, Imai T, Yoshida H, Miyazono M, Takahashi N, Fukuda D, Okada Y, Teragawa H, Suwa S, Kida K, Moroi M, Taguchi I, Toyoda S, Shimabukuro M, Tanabe K, Tanaka K, Nangaku M, Node K. Rationale and design of an investigator-initiated, multicenter, prospective, placebo-controlled, double-blind, randomized trial to evaluate the effects of finerenone on vascular stiffness and cardiorenal biomarkers in type 2 diabetes and chronic kidney disease (FIVE-STAR). Cardiovasc Diabetol 2023;22:194 pubmed

16. Pham PT, Bavuu O, Kim-Kaneyama JR, Lei XF, Yamamoto T, Otsuka K, Suto K, Kusunose K, Yagi S, Yamada H, Soeki T, Shimabukuro M, Barber GN, Sata M, Fukuda D. Innate Immune System Regulated by Stimulator of Interferon Genes, a Cytosolic DNA Sensor, Regulates Endothelial Function. J Am Heart Assoc 2023;12:e030084 pubmed

17. Ueda Y, Hayashi F, Ohira T, Maeda M, Yasumura S, Miura I, Itagaki S, Shimabukuro M, Nakano H, Kamiya K, Yabe H. A Six-Year Prospective Study on Problem Drinking among Evacuees of the Great East Japan Earthquake: The Fukushima Health Management Survey. Int J Environ Res Public Health 2023;20:319 pubmed

18. Yamaguchi S, Shimabukuro M, Tanaka A, Imai T, Hiramitsu S, Takahashi N, Kadokami T, Ajioka M, Suzuki M, Node K. Canagliflozin reduces proteinuria by targeting hyperinsulinaemia in diabetes patients with heart failure: A post hoc analysis of the CANDLE trial. Diabetes Obes Metab 2023;25:354-64 pubmed

19. 
Zhou J, Sun D-Q, Targher G, Byrne CD, Lee B-w, Hamaguchi M, Kim SU, Hou X, Fadini GP, Shimabukuro M, Furuhashi M, Wang N-J, Tilg H, Zheng M-H. Metabolic dysfunction-associated fatty liver disease increases risk of chronic kidney disease: a systematic review and meta-analysis. eGastroenterology 2023;1:e100005 pubmed

英文総説

1. Sakuma M. et al. Possible biomarkers to detect vascular failure: What is known? What should be elucidated? Vasc Fail in press Pubmed

2. Shimabukuro M. L-arginine, nitric oxide, and endothelial dysfunction underlying atherosclerotic cardiovascular disease (ASCVD). J Atheroscler Thromb in press Pubmed

3. Shimabukuro M. Nonsteroidal mineralocorticoid receptor antagonists and protection against cardiovascular disease in patients with diabetes mellitus. J Atheroscler Thromb in press Pubmed

4. Shimabukuro M. MAFLD and ASCVD: plasma heparin cofactor II activity as an anti-liver fibrosis biomarker. J Atheroscler Thromb in press Pubmed

5. Shimabukuro M. MAFLD and small dense LDL cholesterol: a mechanistic link. J Atheroscler Thromb in press Pubmed

英文症例


和文著書

・島袋充生 
日本糖尿病学会専門医取得のための研修必携ガイド 改訂第9版 日本糖尿病学会 印刷中

・益崎裕章ほか 玄米機能成分をめぐる脳科学と分子栄養学 健康と疾患を制御する精密栄養学「何を、いつ、どう食べるか?」に、食品機能の解析と個人差を生む分子メカニズムの解明から迫る 國澤 純/編 実験医学増刊 2023年 Vol.41 No.10

和文総説